Results 101 to 110 of about 277,312 (326)
Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms [PDF]
, 2017 Life expectancy and the number of elderly people are progressively increasing around the world. Together with other pathologies, allergic diseases also show an increasing incidence in geriatric age.
Bonini M +12 more
core +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Atopic dermatitis (AD) is a chronic, itchy skin disease that often begins in infancy and may persist into adulthood. The high co‐occurrence of allergic comorbidities (ACMs; asthma, food allergy, and allergic rhinitis) makes it a growing public health concern.
Masaki Futamura +6 more
wiley +1 more source
IgE Sensitization to Inhalant Allergens and Its Association with Allergic Diseases in Adults
Iranian Journal of Allergy, Asthma and Immunology, 2018 Allergic sensitization to inhalant allergens could be considered as a predictor in allergic diseases. The objective of this study was to assess IgE-mediated sensitization to inhalant allergens in allergic and non-allergic adults as well as the evaluation
Raheleh Shokouhi Shoormasti +11 more
doaj
The Early Efficacy of Topical Levocabastine in Patients with Allergic Conjunctivitis
Allergology International, 2006 Background: We investigated the early efficacy of topical levocabastine, an H1 histamine-receptor antagonist, in improving the clinical symptoms of allergic conjunctivitis. Methods: Thirty-six patients with allergic conjunctivitis were enrolled. One drop
Hiroshi Fujishima +8 more
doaj +1 more source
ACS Applied Materials and Interfaces, 2019 Clinical need for treating allergic conjunctivitis (AC) is rapidly increasing. However, AC relevant anti-inflammatory compounds are generally difficult to solubilize in water, thus limiting their therapeutic potential.
Ning Ren +10 more
semanticscholar +1 more source
Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis [PDF]
, 2021 Yifan Meng +7 more
openalex +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Tralokinumab, an anti‐IL‐13 antibody, is effective for atopic dermatitis (AD); however, its long‐term (> 1 year) effectiveness specific to each anatomical site is unknown in real‐world settings. To evaluate 72‐week effectiveness of tralokinumab on different anatomical sites in AD, we studied 208 patients with moderate‐to‐severe AD treated with
Mizuki Shiba +6 more
wiley +1 more source
Investigative Ophthalmology and Visual Science, 2019 Purpose Several pieces of epidemiologic evidence have indicated PM2.5 (particulate matter with a diameter of 2.5 μm or less) as a causing factor of allergic conjunctivitis, but without experimental elucidation of mechanism. In the present study, PM2.5 in
Yu-Jun Tang +8 more
semanticscholar +1 more source
BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.ABSTRACT Objective To investigate whether the risk of asthma, eczema and allergic rhinitis at 5 years in children born by caesarean section (CS) differs by the timing of antibiotic administration to the mother (pre‐incision vs. post‐cord clamping). Design Natural experiment using birth cohort data. Setting UK single centre population‐based birth cohort.
Lucy Pembrey +7 more
wiley +1 more source
Optimizing the treatment for dry eye syndrome in patients with allergic conjunctivitis
Journal of Ophthalmology, 2020 Background: Allergic conjunctivitis is commonly complicated by secondary dry eye syndrome that substantially affects the quality of life of patients and requires a comprehensive approach to treatment.
F.A. Bakhritdinova +4 more
doaj +1 more source